- Home
- SUPN vs ALKT Comparison
SUPN vs ALKT Comparison
Compare SUPN & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- ALKT
- Stock Information
- Founded
- SUPN 2005
- ALKT 2007
- Country
- SUPN United States
- ALKT United States
- Employees
- SUPN N/A
- ALKT N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- ALKT EDP Services
- Sector
- SUPN Health Care
- ALKT Technology
- Exchange
- SUPN Nasdaq
- ALKT Nasdaq
- Market Cap
- SUPN 2.0B
- ALKT 2.3B
- IPO Year
- SUPN 2012
- ALKT 2021
- Fundamental
- Price
- SUPN $42.00
- ALKT $22.41
- Analyst Decision
- SUPN Buy
- ALKT Buy
- Analyst Count
- SUPN 2
- ALKT 9
- Target Price
- SUPN $41.00
- ALKT $39.89
- AVG Volume (30 Days)
- SUPN 1.0M
- ALKT 1.8M
- Earning Date
- SUPN 08-05-2025
- ALKT 07-30-2025
- Dividend Yield
- SUPN N/A
- ALKT N/A
- EPS Growth
- SUPN 1411.53
- ALKT N/A
- EPS
- SUPN 1.14
- ALKT N/A
- Revenue
- SUPN $665,125,000.00
- ALKT $385,456,000.00
- Revenue This Year
- SUPN N/A
- ALKT $36.31
- Revenue Next Year
- SUPN $15.74
- ALKT $25.07
- P/E Ratio
- SUPN $37.58
- ALKT N/A
- Revenue Growth
- SUPN 5.55
- ALKT 29.63
- 52 Week Low
- SUPN $29.16
- ALKT $19.94
- 52 Week High
- SUPN $43.73
- ALKT $42.29
- Technical
- Relative Strength Index (RSI)
- SUPN 69.63
- ALKT 41.11
- Support Level
- SUPN $40.26
- ALKT $22.43
- Resistance Level
- SUPN $43.73
- ALKT $23.47
- Average True Range (ATR)
- SUPN 1.80
- ALKT 1.22
- MACD
- SUPN 0.31
- ALKT 0.23
- Stochastic Oscillator
- SUPN 84.13
- ALKT 46.58
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About ALKT Alkami Technology Inc.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company's solution, the Alkami Digital Banking Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency, all with the support of a proprietary, true cloud-based, multi-tenant architecture.